SOLTF
Price:
$7.75
Market Cap:
$106.17B
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboratio...[Read more]
Industry
Biotechnology
IPO Date
2013-09-04
Stock Exchange
PNK
Ticker
SOLTF
According to Sosei Group Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 126.26B. This represents a change of -22.03% compared to the average of 161.93B of the last 4 quarters.
The mean historical Enterprise Value of Sosei Group Corporation over the last ten years is 354.77B. The current 126.26B Enterprise Value has changed 3.46% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Enterprise Value was at its highest in in the June 2016 quarter at 1.25T. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.
Average
354.77B
Median
189.25B
Minimum
84.98B
Maximum
1.00T
Discovering the peaks and valleys of Sosei Group Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 188.86%
Maximum Annual Enterprise Value = 1.00T
Minimum Annual Increase = -76.91%
Minimum Annual Enterprise Value = 84.98B
Year | Enterprise Value | Change |
---|---|---|
2023 | 141.22B | 66.18% |
2022 | 84.98B | -33.96% |
2021 | 128.68B | 22.57% |
2020 | 104.98B | -31.89% |
2019 | 154.13B | -76.91% |
2018 | 667.45B | -3.87% |
2017 | 694.35B | -30.63% |
2016 | 1.00T | 188.86% |
2015 | 346.53B | 54.45% |
2014 | 224.37B | 20.85% |
The current Enterprise Value of Sosei Group Corporation (SOLTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
118.29B
5-year avg
122.80B
10-year avg
354.77B
Sosei Group Corporation’s Enterprise Value is greater than Gain Therapeutics, Inc. (36.73M), greater than BioVie Inc. (26.84M), greater than IN8bio, Inc. (9.94M), greater than NewAmsterdam Pharma Company N.V. (1.09B), greater than Cue Biopharma, Inc. (70.94M), greater than uniQure N.V. (517.32M), greater than Rocket Pharmaceuticals, Inc. (1.52B), greater than Rhythm Pharmaceuticals, Inc. (3.33B), greater than Solid Biosciences Inc. (147.89M), greater than MeiraGTx Holdings plc (448.89M), greater than Apellis Pharmaceuticals, Inc. (3.59B), greater than Blueprint Medicines Corporation (6.13B), greater than Karuna Therapeutics, Inc. (12.43B), greater than Mirati Therapeutics, Inc. (3.91B), greater than Day One Biopharmaceuticals, Inc. (1.07B), greater than VectivBio Holding AG (848.58M), greater than AVROBIO, Inc. (-85302404.00), greater than Zura Bio Limited (90.25M), greater than Elevation Oncology, Inc. (2.36M), greater than Hepion Pharmaceuticals, Inc. (1.72M),
Company | Enterprise Value | Market cap |
---|---|---|
36.73M | $52.86M | |
26.84M | $44.57M | |
9.94M | $14.26M | |
1.09B | $1.62B | |
70.94M | $89.71M | |
517.32M | $270.76M | |
1.52B | $1.53B | |
3.33B | $3.24B | |
147.89M | $218.45M | |
448.89M | $461.30M | |
3.59B | $3.48B | |
6.13B | $5.84B | |
12.43B | $12.60B | |
3.91B | $4.12B | |
1.07B | $1.49B | |
848.58M | $1.06B | |
-85302404.00 | $5.24M | |
90.25M | $278.69M | |
2.36M | $30.89M | |
1.72M | $3.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sosei Group Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sosei Group Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sosei Group Corporation's Enterprise Value?
What is the highest Enterprise Value for Sosei Group Corporation (SOLTF)?
What is the 3-year average Enterprise Value for Sosei Group Corporation (SOLTF)?
What is the 5-year average Enterprise Value for Sosei Group Corporation (SOLTF)?
How does the current Enterprise Value for Sosei Group Corporation (SOLTF) compare to its historical average?